AgiBot develops and manufactures humanoid robots and embodied intelligence systems designed for various applications, including interactive services and flexible manufacturing. Their technology enhances productivity by automating tasks in diverse environments, addressing labor shortages and operational inefficiencies.

Cali Biosciences develops innovative perioperative drugs, including anesthetics, analgesics, and anti-inflammatories, targeting unmet needs in global markets. Their pipeline focuses on complex injectable formulations with high technological barriers to entry, seeking regulatory approval in China, the US, and the EU. The company aims to improve patient outcomes and quality of life through novel pharmaceutical solutions.

The startup develops TCR gene therapy solutions that provide personalized immunotherapy for cancer patients by engineering T-cell receptors to target specific tumor antigens. This approach enhances treatment efficacy and minimizes side effects compared to traditional therapies.